Adjusted Ebitda can be a useful tool, but it should not be relied on as the sole indicator of a company’s financial health.

CALGARY, Alberta, March 13, 2025 (GLOBE NEWSWIRE) -- March 13, 2025 - Sylogist Ltd. (TSX: SYZ) ("Sylogist" or the "Company"), a leading public sector SaaS company, today announced its results for the ...

Chemed’s EBITDA, Adjusted EBITDA and Adjusted Diluted EPS should not be considered in isolation or as a substitute for comparable measures calculated and presented in accordance with GAAP. We ...

Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of ...

In a slightly slowing but still hot RIA M&A landscape, we are seeing an increasing number of private-equity firms favoring adjusted Ebitda as a valuation method.